Want to join the conversation?
$BAX 2Q15 PR: Worldwide sales totaled $3.9Bil, a decline of 6% from the same period last year. Excluding the impact of FX, Baxter’s worldwide sales grew 3% exceeding the company’s guidance of 1%. Baxter posted net income of $332MM compared to $520MM in 2Q14. On an adjusted basis, excluding special items, Baxter’s 2Q15 net income totaled $550MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?